Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 22635230)

1.

Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome.

De Carolis S, Botta A, Santucci S, Salvi S, Moresi S, Di Pasquo E, Del Sordo G, Martino C.

Lupus. 2012 Jun;21(7):776-8. doi: 10.1177/0961203312444172.

PMID:
22635230
2.

Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.

Ramos-Casals M, Campoamor MT, Chamorro A, Salvador G, Segura S, Botero JC, Yagüe J, Cervera R, Ingelmo M, Font J.

Lupus. 2004;13(10):777-83.

PMID:
15540510
3.

Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications?

Reggia R, Ziglioli T, Andreoli L, Bellisai F, Iuliano A, Gerosa M, Ramoni V, Tani C, Brucato A, Galeazzi M, Mosca M, Caporali R, Meroni PL, Tincani A.

Rheumatology (Oxford). 2012 Dec;51(12):2186-90. doi: 10.1093/rheumatology/kes225. Epub 2012 Aug 25.

4.

High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome.

Simchen MJ, Dulitzki M, Rofe G, Shani H, Langevitz P, Schiff E, Pauzner R.

Acta Obstet Gynecol Scand. 2011 Dec;90(12):1428-33. doi: 10.1111/j.1600-0412.2011.01236.x. Epub 2011 Aug 29.

PMID:
21729009
5.

Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study.

Del Ross T, Ruffatti A, Visentin MS, Tonello M, Calligaro A, Favaro M, Hoxha A, Punzi L.

J Rheumatol. 2013 Apr;40(4):425-9. doi: 10.3899/jrheum.120576. Epub 2013 Feb 15.

PMID:
23418380
6.

A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group.

Branch DW, Peaceman AM, Druzin M, Silver RK, El-Sayed Y, Silver RM, Esplin MS, Spinnato J, Harger J.

Am J Obstet Gynecol. 2000 Jan;182(1 Pt 1):122-7.

PMID:
10649166
7.

Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome.

Caruso A, De Carolis S, Ferrazzani S, Valesini G, Caforio L, Mancuso S.

Obstet Gynecol. 1993 Dec;82(6):970-7.

PMID:
8233274
8.

The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards.

Lackman F, Capewell V, Richardson B, daSilva O, Gagnon R.

Am J Obstet Gynecol. 2001 Apr;184(5):946-53.

PMID:
11303203
9.

[C3 and C4 hypocomplementemia in obstetric antiphospholipid syndrome].

Carbone J, Sarmiento E, Rodríguez-Molina J, Fernández-Cruz E.

Rev Clin Esp. 2008 Mar;208(3):170-1. Spanish. No abstract available.

PMID:
18275778
10.

A study of 75 pregnancies in patients with antiphospholipid syndrome.

Huong DL, Wechsler B, Bletry O, Vauthier-Brouzes D, Lefebvre G, Piette JC.

J Rheumatol. 2001 Sep;28(9):2025-30.

PMID:
11550970
11.

Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies.

Donohoe S, Quenby S, Mackie I, Panal G, Farquharson R, Malia R, Kingdom J, Machin S.

Lupus. 2002;11(1):11-20.

PMID:
11898913
12.
13.

Longitudinal analysis of serum insulin-like growth factor-I and insulin-like growth factor binding protein-1 in antiphospholipid syndrome and in healthy pregnancy.

Stone S, Langford K, Seed PT, Khamashta MA, Hunt BJ, Poston L.

Am J Obstet Gynecol. 2003 Jul;189(1):274-9.

PMID:
12861174
14.

Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome.

Ruffatti A, Calligaro A, Hoxha A, Trevisanuto D, Ruffatti AT, Gervasi MT, Cuffaro S, Pengo V, Punzi L.

Arthritis Care Res (Hoboken). 2010 Mar;62(3):302-7. doi: 10.1002/acr.20098.

PMID:
20391475
15.

Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss.

Cohen D, Buurma A, Goemaere NN, Girardi G, le Cessie S, Scherjon S, Bloemenkamp KW, de Heer E, Bruijn JA, Bajema IM.

J Pathol. 2011 Dec;225(4):502-11. doi: 10.1002/path.2893. Epub 2011 Jun 20.

PMID:
21688269
16.

The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus.

Clowse ME, Magder LS, Petri M.

J Rheumatol. 2011 Jun;38(6):1012-6. doi: 10.3899/jrheum.100746. Epub 2011 Mar 16.

PMID:
21406496
17.

Pregnancy outcomes in patients with systemic autoimmunity.

Canti V, Castiglioni MT, Rosa S, Franchini S, Sabbadini MG, Manfredi AA, Rovere-Querini P.

Autoimmunity. 2012 Mar;45(2):169-75. doi: 10.3109/08916934.2011.593600. Epub 2011 Aug 30.

PMID:
21875380
18.

[Risk factors for low birth weight and intrauterine growth retardation in Santiago, Chile].

Vega J, Sáez G, Smith M, Agurto M, Morris NM.

Rev Med Chil. 1993 Oct;121(10):1210-9. Spanish.

PMID:
8191127
19.

Predictors of pregnancy outcome in antiphospholipid syndrome: a review.

De Carolis S, Botta A, Santucci S, Garofalo S, Martino C, Perrelli A, Salvi S, Ferrazzani S, Caforio L, Scambia G.

Clin Rev Allergy Immunol. 2010 Apr;38(2-3):116-24. doi: 10.1007/s12016-009-8144-z. Review.

PMID:
19557318
20.

The relationship between TORCH complex false positivity and obstetric outcome in patients with antiphospholipid syndrome.

De Carolis S, Santucci S, Botta A, Salvi S, Degennaro VA, Garufi C, Garofalo S, Ferrazzani S, Scambia G.

Lupus. 2012 Jun;21(7):773-5. doi: 10.1177/0961203312447866.

PMID:
22635229
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk